CO2 CD129
CO2 CD129 is a medical device (FDA Class II; FDA product code KHS, Enzymatic, Carbon-Dioxide) made by Randox Laboratories, Ltd., cleared under FDA 510(k) K951221 on 15 Feb 1996 and listed in FDA GUDID since 16 Sep 2016 (UDI-DI 05055273201031), active as of 22 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number05055273201031 | Date16 Sep 2016 | StatusListed |
| United States | FDA 510(k)SESE | NumberK951221 | Date15 Feb 1996 | StatusActive |
Official records
- AccessGUDID record 05055273201031
- FDA 510(k) database K951221
Across registries
- FDA 510(k) K951221 decided 15 Feb 1996 Active
- FDA GUDID UDI-DI 05055273201031 listed 16 Sep 2016 Listed
Timeline
- Cleared FDA 510(k) K951221
- Listed FDA GUDID 05055273201031
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- CO2
- Generic name
- Bicarbonate (HCO3-) IVD, reagent
- Model / Ref / Catalog
- CD129
- Primary DI / UDI-DI
- 05055273201031
- 510(k) Number
- FDA product code
- KHS
- GMDN term
- Bicarbonate (HCO3-) IVD, reagent
- Device class
- Class II
- Regulation number
- 862.1160
- GUDID distribution status
- In Commercial Distribution
Similar devices
Other devices filed under FDA product code KHS (Enzymatic, Carbon-Dioxide).
- Diazyme DZ122A-KY1 by Diazyme Laboratories, Inc.
- CARBON DIOXIDE - DST by Trace America, Inc.
- CARBON DIOXIDE (CO2), PRODUCT NO. CC0107-01 by A.P. Total Care, Inc.
- CARBON DIOXIDE REAGENT by POINTE SCIENTIFIC, INC.
- JAS CARBON DIOXIDE LIQUID REAGENT by Jas Diagnostic, Inc.
- COULTER CARBON DIOXIDE REAGENT by Coulter Corp.
- Diazyme DZ122A-CAL by Diazyme Laboratories, Inc.
- BICARBONATE TEST ITEM NUMBER: SR1006 by Em Diagnostic Systems, Inc.
- CARBON DIOXIDE - L3K ASSAY, CATALOGUE NUMBER 299-30/40/50 by Diagnostic Chemicals, Ltd.
- ADVIA Chemistry CO2_c 10720780 by Siemens Healthcare Diagnostics Inc.